Other impetigo
ICD-10 L01.09 is a billable code used to indicate a diagnosis of other impetigo.
L01.09 refers to 'Other impetigo,' a bacterial skin infection primarily caused by Staphylococcus aureus or Streptococcus pyogenes. Clinically, impetigo presents as vesicular lesions that rupture, leading to honey-colored crusts, typically on the face, arms, and legs. The condition is most common in children but can affect individuals of any age. The disease progression often begins with minor skin trauma, allowing bacteria to invade the epidermis. Diagnosis is primarily clinical, based on the characteristic appearance of the lesions, although laboratory confirmation may be necessary in atypical cases. Differential diagnoses include contact dermatitis, herpes simplex, and other vesicular diseases. Treatment typically involves topical antibiotics for localized cases and systemic antibiotics for widespread infections. Proper hygiene and wound care are essential to prevent recurrence and spread. Understanding the anatomy involved, particularly the epidermis and dermis, is crucial for effective management and prevention of complications such as cellulitis or systemic infection.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L01.09 covers cases of impetigo that do not fit the more common categories, including atypical presentations or those caused by less common pathogens. It is essential to document the specific characteristics of the lesions and any underlying conditions that may contribute to the infection.
L01.09 should be used when the impetigo presentation is not typical or when it is caused by organisms other than those specified in related codes. Clear documentation of the clinical presentation and any diagnostic tests performed is necessary to justify the use of this code.
Documentation should include a detailed description of the lesions, their location, duration, and any associated symptoms. Clinical notes should also reflect the treatment plan and response to therapy, along with any relevant laboratory results.
